Mesenchymal stem cells promote cisplatin resistance in non-small cell lung cancer through IL-6/MEK-ERK/macrophages axis: construction of prognostic signature and experimental investigation. This evidence concerns the gene MAP2K7 and non-small cell lung carcinoma.